Zibetti, Maurizio

Gut Microbiota and Metabolome Distinctive Features in Parkinson Disease: Focus on Levodopa and Levodopa-carbidopa Intrajejunal Gel

Melis, M., Vascellari, S., Santoru, M. L., Oppo, V., Fabbri, M., Sarchioto, M., Murgia, D., Zibetti, M., Lopiano, L., Serra, A., et al. (2021) · European Journal of Neurology

Gut microbiota and healthParkinson's Disease Mechanisms and Treatments

Cited by 37

The placebo effect on bradykinesia in Parkinson's disease with and without prior drug conditioning

Frisaldi, E., Carlino, E., Zibetti, M., Barbiani, D., Dematteis, F., Lanotte, M., Lopiano, L., & Benedetti, F. (2017) · Movement Disorders

Pain Management and Placebo EffectParkinson's Disease Mechanisms and Treatments

Cited by 35

Impulse control disorder and response-inhibition alterations in Parkinson’s disease. A rare case of totally absent functionality of the medial-prefrontal cortex and review of literature

Palermo, S., Morese, R., Zibetti, M., Dematteis, F., Sirgiovanni, S., Stanziano, M., Valentini, M. C., & Lopiano, L. (2017) · Journal of Advanced Research

Parkinson's Disease Mechanisms and TreatmentsNeural and Behavioral Psychology Studies

Cited by 30

Role of the Cingulate Cortex in Dyskinesias-Reduced-Self-Awareness: An fMRI Study on Parkinson’s Disease Patients

Palermo, S., Lopiano, L., Morese, R., Zibetti, M., Romagnolo, A., Stanziano, M., Rizzone, M. G., Geminiani, G. C., Valentini, M. C., & Amanzio, M. (2018) · Frontiers in Psychology

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 28